Jain Anu, Queiroz Rafaela Muniz de, Chakrabarty Jayanta K, Makepeace Karl A T, Prives Carol, Brown Lewis M
Department of Biological Sciences, Columbia University, New York, NY 10027, USA.
Quantitative Proteomics and Metabolomics Center, Columbia University, New York, NY 10027, USA.
Proteomes. 2025 May 22;13(2):18. doi: 10.3390/proteomes13020018.
We utilized data-independent acquisition (DIA) to study the poorly understood biology of Mdm2 and MdmX in a p53-null context. Mdm2 and MdmX form an E3-ligase complex that has as its most well-studied function the negative regulation of the tumor suppressor p53; however, it is also known to interact with many other proteins in a p53-independent manner.
In this work, small-molecule and siRNA-based technology were used to modify Mdm2/MdmX activity in a human non-small-cell lung carcinoma cell line lacking p53 expression. Study of the proteome of these cells helped identify biological processes where Mdm2 and MdmX may play roles in a p53-independent manner. Proteins from H1299 cells, treated with the drug MEL23 or siRNA against Mdm2 or MdmX, were analyzed.
Protein ontology and function were analyzed, revealing which pathways are affected by modulation of the proteins that form the complex. Insights into how those functions are dependent on the activity of the complex also gained via comparisons among the three groups of samples.
We selected a potential target from the DIA analysis and validated it by immunoblotting and qPCR, and this allows us to demonstrate a new interaction partner of the Mdm2-MdmX complex in human cells.
我们利用数据非依赖型采集(DIA)技术,在p53缺失的背景下研究了解甚少的Mdm2和MdmX生物学特性。Mdm2和MdmX形成一种E3连接酶复合物,其最广为人知的功能是对肿瘤抑制因子p53进行负调控;然而,已知它还能以不依赖p53的方式与许多其他蛋白质相互作用。
在这项研究中,我们使用小分子和基于小干扰RNA(siRNA)的技术,在缺乏p53表达的人非小细胞肺癌细胞系中改变Mdm2/MdmX的活性。对这些细胞的蛋白质组进行研究,有助于确定Mdm2和MdmX可能以不依赖p53的方式发挥作用的生物学过程。分析了用药物MEL23或针对Mdm2或MdmX的siRNA处理的H1299细胞中的蛋白质。
分析了蛋白质本体和功能,揭示了形成复合物的蛋白质的调节会影响哪些信号通路。通过对三组样本的比较,也深入了解了这些功能如何依赖于复合物的活性。
我们从DIA分析中选择了一个潜在靶点,并通过免疫印迹和定量聚合酶链反应(qPCR)对其进行了验证,这使我们能够在人类细胞中证明Mdm2-MdmX复合物的一个新的相互作用伙伴。